Avacta Group is a Bio-Technology company focusing on “cancer treatments with powerful therapeutic and diagnostic platforms.”
They have also used this technology to devise a COVID-19 rapid diagnostic test. They updated the market this morning that their technology maybe a potential therapy for blocking Covid-19.
